Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1989 May;48(5):358–361. doi: 10.1136/ard.48.5.358

Antiphospholipid antibodies: a risk factor for occlusive ocular vascular disease in systemic lupus erythematosus and the 'primary' antiphospholipid syndrome.

R A Asherson 1, P Merry 1, J F Acheson 1, E N Harris 1, G R Hughes 1
PMCID: PMC1003763  PMID: 2637678

Abstract

Seven cases of occlusive ocular vascular disease affecting retinal and choroidal vessels were found among 84 consecutive patients with raised levels of anticardiolipin antibodies attending the lupus arthritis clinic at St Thomas's Hospital from 1985 to 1987. Six patients with systemic lupus erythematosus (SLE) and one with a 'primary antiphospholipid syndrome' had occlusive ocular vascular disease affecting a variety of vessels. This gives a prevalence of occlusive ocular vascular disease of 8% in this subgroup of patients, significantly higher than the 0.5-2.0% previously reported in patients with SLE. Four of these patients also suffered from cerebrovascular disease, supporting the previously documented association between occlusive ocular vascular disease and central nervous system disease in SLE. Additionally, other features of the antiphospholipid syndrome were frequently present. These findings suggest that patients with SLE and raised anticardiolipin antibodies have a higher risk of developing occlusive ocular vascular disease than has been previously reported.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asherson R. A., Gibson D. G., Evans D. W., Baguley E., Hughes G. R. Diagnostic and therapeutic problems in two patients with antiphospholipid antibodies, heart valve lesions, and transient ischaemic attacks. Ann Rheum Dis. 1988 Nov;47(11):947–953. doi: 10.1136/ard.47.11.947. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Asherson R. A., Harris E. N. Anticardiolipin antibodies--clinical associations. Postgrad Med J. 1986 Dec;62(734):1081–1087. doi: 10.1136/pgmj.62.734.1081. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Asherson R. A., Lubbe W. F. Cerebral and valve lesions in SLE: association with antiphospholipid antibodies. J Rheumatol. 1988 Apr;15(4):539–543. [PubMed] [Google Scholar]
  4. Bishko F. Retinopathy in systemic lupus erythematosus. A case report and review of the literature. Arthritis Rheum. 1972 Jan-Feb;15(1):57–63. doi: 10.1002/art.1780150109. [DOI] [PubMed] [Google Scholar]
  5. CLIFTON F., GREER C. H. Ocular changes in acute systemic lupus erythematosus. Br J Ophthalmol. 1955 Jan;39(1):1–10. doi: 10.1136/bjo.39.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cronin M. E., Biswas R. M., Van der Straeton C., Fleisher T. A., Klippel J. H. IgG and IgM anticardiolipin antibodies in patients with lupus with anticardiolipin antibody associated clinical syndromes. J Rheumatol. 1988;15(5):795–798. [PubMed] [Google Scholar]
  7. Ford P. M., Ford S. E., Lillicrap D. P. Association of lupus anticoagulant with severe valvular heart disease in systemic lupus erythematosus. J Rheumatol. 1988 Apr;15(4):597–600. [PubMed] [Google Scholar]
  8. Gastineau D. A., Kazmier F. J., Nichols W. L., Bowie E. J. Lupus anticoagulant: an analysis of the clinical and laboratory features of 219 cases. Am J Hematol. 1985 Jul;19(3):265–275. doi: 10.1002/ajh.2830190308. [DOI] [PubMed] [Google Scholar]
  9. Gharavi A. E., Harris E. N., Asherson R. A., Hughes G. R. Anticardiolipin antibodies: isotype distribution and phospholipid specificity. Ann Rheum Dis. 1987 Jan;46(1):1–6. doi: 10.1136/ard.46.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gold D. H., Morris D. A., Henkind P. Ocular findings in systemic lupus erythematosus. Br J Ophthalmol. 1972 Nov;56(11):800–804. doi: 10.1136/bjo.56.11.800. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Graham E. M., Spalton D. J., Barnard R. O., Garner A., Russell R. W. Cerebral and retinal vascular changes in systemic lupus erythematosus. Ophthalmology. 1985 Mar;92(3):444–448. doi: 10.1016/s0161-6420(85)34018-6. [DOI] [PubMed] [Google Scholar]
  12. Hall S., Buettner H., Luthra H. S. Occlusive retinal vascular disease in systemic lupus erythematosus. J Rheumatol. 1984 Dec;11(6):846–850. [PubMed] [Google Scholar]
  13. Hughes G. R., Harris N. N., Gharavi A. E. The anticardiolipin syndrome. J Rheumatol. 1986 Jun;13(3):486–489. [PubMed] [Google Scholar]
  14. Jabs D. A., Fine S. L., Hochberg M. C., Newman S. A., Heiner G. G., Stevens M. B. Severe retinal vaso-occlusive disease in systemic lupus erythematous. Arch Ophthalmol. 1986 Apr;104(4):558–563. doi: 10.1001/archopht.1986.01050160114025. [DOI] [PubMed] [Google Scholar]
  15. Jabs D. A., Miller N. R., Newman S. A., Johnson M. A., Stevens M. B. Optic neuropathy in systemic lupus erythematosus. Arch Ophthalmol. 1986 Apr;104(4):564–568. doi: 10.1001/archopht.1986.01050160120026. [DOI] [PubMed] [Google Scholar]
  16. Jonas J., Kölble K., Völcker H. E., Kalden J. R. Central retinal artery occlusion in Sneddon's disease associated with antiphospholipid antibodies. Am J Ophthalmol. 1986 Jul 15;102(1):37–40. doi: 10.1016/0002-9394(86)90206-0. [DOI] [PubMed] [Google Scholar]
  17. Lanham J. G., Barrie T., Kohner E. M., Hughes G. R. SLE retinopathy: evaluation by fluorescein angiography. Ann Rheum Dis. 1982 Oct;41(5):473–478. doi: 10.1136/ard.41.5.473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Lechner K., Pabinger-Fasching I. Lupus anticoagulants and thrombosis. A study of 25 cases and review of the literature. Haemostasis. 1985;15(4):254–262. doi: 10.1159/000215157. [DOI] [PubMed] [Google Scholar]
  19. McHugh N. J., Maymo J., Skinner R. P., James I., Maddison P. J. Anticardiolipin antibodies, livedo reticularis, and major cerebrovascular and renal disease in systemic lupus erythematosus. Ann Rheum Dis. 1988 Feb;47(2):110–115. doi: 10.1136/ard.47.2.110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Merry P., Acheson J. F., Asherson R. A., Hughes G. R. Management of retinal vein occlusion. Br Med J (Clin Res Ed) 1988 Jan 23;296(6617):294–294. doi: 10.1136/bmj.296.6617.294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. SNEDDON I. B. CEREBRO-VASCULAR LESIONS AND LIVEDO RETICULARIS. Br J Dermatol. 1965 Apr;77:180–185. doi: 10.1111/j.1365-2133.1965.tb14628.x. [DOI] [PubMed] [Google Scholar]
  22. Silverman M., Lubeck M. J., Briney W. G. Central retinal vein occlusion complicating systemic lupus erythematosus. Arthritis Rheum. 1978 Sep-Oct;21(7):839–843. doi: 10.1002/art.1780210716. [DOI] [PubMed] [Google Scholar]
  23. Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., Schaller J. G., Talal N., Winchester R. J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 Nov;25(11):1271–1277. doi: 10.1002/art.1780251101. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES